DECIPHERA PHARMACEUTICALS IN (DCPH)
Institutional ownership reported to the SEC as of Q2 2024, across 23 quarters.
1
Reporting holders
$759
Reported value
0.0%
Held as options
-159
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | $759 | 50,000 | 0.00% | 3q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2024 | 1 | $759 | 50,000 | 0 | 0 | 0 | 0.0% |
| Q1 2024 | 160 | $979.2M | 62,350,016 | 26 | 57 | 42 | 0.1% |
| Q4 2023 | 145 | $957.8M | 59,609,326 | 19 | 60 | 35 | 0.1% |
| Q3 2023 | 136 | $704.7M | 55,485,677 | 19 | 40 | 49 | 0.0% |
| Q2 2023 | 128 | $775.9M | 55,031,693 | 14 | 46 | 37 | 0.1% |
| Q1 2023 | 125 | $849.8M | 54,959,241 | 24 | 51 | 31 | 0.1% |
| Q4 2022 | 119 | $757.6M | 46,465,231 | 14 | 40 | 41 | 4.3% |
| Q3 2022 | 153 | $916.7M | 49,106,915 | 35 | 55 | 33 | 0.9% |
| Q2 2022 | 130 | $641.5M | 48,059,993 | 26 | 45 | 36 | 1.0% |
| Q1 2022 | 122 | $411.8M | 43,618,279 | 17 | 39 | 41 | 1.0% |
| Q4 2021 | 141 | $486.0M | 46,365,388 | 29 | 57 | 32 | 6.1% |
| Q3 2021 | 164 | $1.5B | 42,726,861 | 29 | 45 | 45 | 1.5% |
| Q2 2021 | 149 | $1.6B | 43,486,290 | 14 | 56 | 54 | 1.2% |
| Q1 2021 | 171 | $2.0B | 43,371,055 | 17 | 58 | 55 | 1.2% |
| Q4 2020 | 189 | $2.5B | 43,641,752 | 28 | 69 | 48 | 1.9% |
| Q3 2020 | 167 | $2.2B | 42,686,948 | 16 | 62 | 54 | 2.0% |
| Q2 2020 | 174 | $2.6B | 42,912,752 | 35 | 69 | 45 | 1.9% |
| Q1 2020 | 151 | $1.7B | 40,841,466 | 32 | 55 | 44 | 1.4% |
| Q4 2019 | 155 | $2.4B | 36,009,137 | 43 | 60 | 34 | 4.8% |
| Q3 2019 | 122 | $1.2B | 35,906,001 | 49 | 49 | 18 | 1.2% |
| Q2 2019 | 91 | $548.1M | 23,275,543 | 24 | 37 | 15 | 4.2% |
| Q1 2019 | 80 | $523.6M | 22,560,006 | 11 | 23 | 23 | 0.0% |
| Q4 2018 | 79 | $463.5M | 22,072,277 | 3 | 3 | 2 | 0.1% |